Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Casterella

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers of Radiation Therapy and Oncology|May 16, 2001
Restenosis: an overviewP J Casterella
Cardiology in Review|July 29, 1999
Prevention of coronary restenosisP J Casterella, P S Teirstein
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variableP J Casterella, D J Kereiakes, S R Steinhubl, et al.
Circulation|May 31, 2001
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter studyS R Steinhubl, J D Talley, G A Braden, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers of Radiation Therapy and Oncology|May 16, 2001
Restenosis: an overviewP J Casterella
Cardiology in Review|July 29, 1999
Prevention of coronary restenosisP J Casterella, P S Teirstein
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variableP J Casterella, D J Kereiakes, S R Steinhubl, et al.
Circulation|May 31, 2001
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter studyS R Steinhubl, J D Talley, G A Braden, et al.
Pageof 1